Dark
Light
System
Security
PROVECTUS BIOPHARMACEUTICALS
PROVECTUS BIOPHARMACEUTICALS. Institutional holdings reported to the SEC.

Institutional Holders (2016Q1)
Portfolio Summary: 3 Institutional holders with a total value of $540,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 Cormorant Asset Management, LP 2,200,000 440,000 81.48%
2 MILLENNIUM MANAGEMENT LLC 500,000 100,000 18.52%
3 UBS Group AG 425 0 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.